ADC Linker and Conjugation Summit
Evvnt Promotion / evvnt
Archive

22.08.2023 - 24.08.2023 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 9:00 am - 3:05 pm
Conference themes
As the proportion of clinically site-specific ADCs increases, the abundance of novel conjugation technologies diversifies, and the linker chemistry toolkit is expanded, investments in linker and conjugation technologies have become the single-biggest area of investment for ADC drug developers.
As the proportion of clinically site-specific ADCs increases, the abundance of novel conjugation technologies diversifies, and the linker chemistry toolkit is expanded, investments in linker and conjugation technologies have become the single-biggest area of investment for ADC drug developers.
Professional congress organizer (PCO)
Hanson Wade Group
Hanson Wade Group
Notes
URL:
Brochure: https://go.evvnt.com/1646328-3?pid=4832
Speakers: Abbas El Sahili | CEO | Singzyme, BinQing Wei | Senior Scientist | Genentech Inc, Donglu Zhang | Senior Fellow - Drug Metabolism and Pharmacokinetics | Genentech Inc, and more.
URL:
Brochure: https://go.evvnt.com/1646328-3?pid=4832
Speakers: Abbas El Sahili | CEO | Singzyme, BinQing Wei | Senior Scientist | Genentech Inc, Donglu Zhang | Senior Fellow - Drug Metabolism and Pharmacokinetics | Genentech Inc, and more.
Enquiries and Registration:
http://go.evvnt.com/1646328-2?pid=4832
Ms. Jessica Durston
Public Health
Languages
English
English
Congress fees
USD 2599.00 - USD 5297.00
USD 2599.00 - USD 5297.00
Participants expected
1000 - 1000
1000 - 1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."